Analysts expect Pacira BioSciences, Inc. to report revenue of 179.21 M for Q3 26, against a range of 164.98 M to 193.44 M. The most recent reported quarter, Q2 26, came in at 192.40 M, a 3.0% beat against the 186.85 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 168.57 M | 187.25 M | 168.92 M | 181.10 M | 179.52 M | 196.87 M | 177.38 M | 192.40 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 188.10 M | 205.97 M | 203.15 M | 199.97 M | 205.01 M | 213.41 M | 175.56 M | 194.17 M | 193.44 M | 198.69 M | 194.50 M | 193.99 M | 203.19 M | 233.97 M | 224.81 M | 255.84 M | ||||||||||
| Low Estimate | 168.18 M | 186.18 M | 173.20 M | 181.33 M | 181.20 M | 175.17 M | 155.00 M | 179.53 M | 164.98 M | 183.46 M | 175.34 M | 178.40 M | 167.49 M | 203.10 M | 207.60 M | 213.54 M | ||||||||||
| Consensus Estimate | 178.14 M | 196.08 M | 188.17 M | 190.65 M | 193.11 M | 194.29 M | 165.28 M | 186.85 M | 179.21 M | 191.08 M | 184.92 M | 186.19 M | 185.34 M | 218.54 M | 216.21 M | 234.69 M |
Analysts expect Pacira BioSciences, Inc. to report earnings per share of 0.76 for Q3 26, against a range of 0.73 to 0.79. The most recent reported quarter, Q2 26, came in at 0.73, a 5.8% beat against the 0.69 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.79 | 0.91 | 0.62 | 0.74 | 0.70 | 0.57 | 0.60 | 0.73 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.76 | 0.94 | 0.65 | 0.80 | 0.77 | 1.02 | 0.64 | 0.75 | 0.79 | 0.84 | 0.75 | 0.80 | 0.89 | 0.99 | 1.06 | 1.18 | ||||||||||
| Low Estimate | 0.68 | 0.84 | 0.57 | 0.68 | 0.67 | 0.86 | 0.54 | 0.63 | 0.73 | 0.76 | 0.69 | 0.72 | 0.79 | 0.93 | 0.92 | 1.02 | ||||||||||
| Consensus Estimate | 0.72 | 0.89 | 0.61 | 0.74 | 0.72 | 0.94 | 0.59 | 0.69 | 0.76 | 0.80 | 0.72 | 0.76 | 0.84 | 0.96 | 0.99 | 1.10 |
Pull Wall Street consensus for Pacira BioSciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PCRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PCRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PCRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();